New stent aims to safely treat brain aneurysms

NCT ID NCT03957382

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is checking whether the Accero stent is safe and works well for people with brain aneurysms. Researchers are following 130 patients who already received the stent as part of routine care. They will use imaging and disability scales to see how patients do over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Accero® (heal) Stent (a medical device placed in a blood vessel to treat a brain aneurysm)
What this could lead to
If successful, this could confirm that the Accero stent is a safe and effective option for treating brain aneurysms, helping prevent rupture.
What could go wrong
This is a post-market study, not a randomized trial, so results may not prove superiority over other treatments. Risks include typical stent complications like blood clots or vessel damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACRANIAL ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • KLINIKUM VEST GMBH Knappschaftskrankenhaus Klinik für Radiologie und Neuroradiologie

    Recklinghausen, 45657, Germany

  • Klinik und Poliklinik für Neuroradiologische Diagnostik und Intervention, Universitätsklinikum Hamburg-Eppendorf

    Hamburg, Free and Hanseatic City of Hamburg, 20246, Germany

  • Krankenhaus Ludmillenstift, Abteilung für Radiologie, Neuroradiologie und Nuklearmedizin

    Meppen, 49716, Germany

  • Vivantes - Klinikum Neukölln Institut für klinische und interventionelle Neuroradiologie

    Berlin, 12351, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.